• Special Issue Topic

    Old and New Paradigms in Viral Vaccinology

    Submission Deadline: February 20, 2023

    Guest Editors

    Dr. Marc H.V. Van Regenmortel E-Mail

    Retired Emeritus CNRS Director, School of Biotechnology, 300 Boulevard Sébastien Brant, 67412 ILLKIRCH, France

    Research Keywords: General virology, immunochemistry of viruses, viral taxonomy, synthetic peptide vaccine, viral diagnostics, SPR biosensors

    Dr. Vladimir N. Uversky E-Mail

    Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 07 Tampa, Forida 33612, USA

    Research Keywords: Protein folding, misfolding and non-folding, intrinsically disordered proteins (IDPs), spectroscopy, molecular biology, bioinformatics

    About the Special Issue

    Thomas Kuhn [1] in "The Structure of Scientific Revolutions" introduced the term paradigm to refer to the conceptual framework that scientists use when they try to solve a particular problem. A paradigm consists of a number of hypotheses, presuppositions and theoretical assumptions that guide the experimental approaches that scientists choose to follow in their investigations. These underlying assumptions are often not explicitly stated because they are not based on established certainties. A theory for instance always consists of a cluster of interrelated explanatory models of a scientific phenomenon together with a number of auxiliary hypotheses that must be present in order to link the models with actual systems in the real world [2, p 85]. A theory may then achieve a certain level of predictive success for explaining a phenomenon but it can never achieve absolute certainty and the history of science has indeed shown that many accepted theories were subsequently shown to be false when additional empirical evidence became available. This is often due to the fact that some of the auxiliary hypotheses that were supposed to be fulfilled when the theory was tested were in fact not valid. In addition, when a theory appears to be consistent with experimental evidence, this may simply be due to the fact that some of these hypotheses just happened to be fulfilled. This means that all scientific theories remain tentative and that further experimentation may always reveal that when certain testing conditions are modified, the theory no longer applies.

    The logical positivists in the last century believed that inductive generalizations (for instance that all the swans we have ever seen are white) can be transformed by deduction into a valid scientific law that claims that every swan is necessarily white. Attempts to reach logical certainties by induction were eventually abandoned when it was admitted that if humans went on collecting additional empirical evidence, they might be forced to accept for instance that black swans also exist.

    Few scientists today believe that scientific reasoning can lead to absolutely certain deductions and they resist the temptation of accepting that their current hypotheses, theories and paradigms are necessarily correct since they view them as logically uncertain assumptions that always need to be empirically verified. Although scientists in their investigations mostly operate within shared tentative paradigms and assumptions, when they obtain results that are incompatible with the paradigm, they tend to invent new ad-hoc hypotheses to rescue the paradigm rather than abandoning it because their main aim is not to prove the validity of their chosen paradigm. In vaccinology, the choice of a valid paradigm is particularly difficult because the extreme complexity of immune systems makes it difficult to guess what are the mechanisms that lead to the development of protective antibodies in vaccinees who are able of overcoming the detrimental activities of pathogens. Another motive that makes investigators retain a paradigm is that the human mind is prone to numerous psychological convictions and biases, for instance "confirmation bias" which leads scientists to give more weight to their favorite hypotheses or paradigms rather than to the negative results of their experiments when these are in blatant contradiction with the paradigm [3].

    Since the so-called scientific method is no longer accepted to provide a reliable procedure for reaching scientific certainties [4], relying on valid paradigms for solving scientific problems is also no longer an essential condition that guarantees that a correct solution to a scientific problem will be found. The term paradigm nevertheless continues to be used for referring to a particular approach to try to solve scientific problems. Kuhn [1] himself admitted that he had never clearly defined the concept of paradigm with the result that the term was used in so many ways that it came to signify any dominant idea that binds a scientific community together. He subsequently proposed that "paradigm" should be replaced by "exemplar" to refer to exemplary instances of successful solutions for scientific problems. However, the term paradigm continued to be used in spite of its ambiguity and of its inability, for instance, to lead to an effective HIV-1 vaccine by rational design [5].


    1. Kuhn TS. The Structure of Scientific Revolutions. Chicago, IL: University of Chicago Press: 1962.

    2. Giere RN. Explaining Science. Chicago, IL; University of Chicago Press: 1988.

    3. Kahneman D. Thinking, Fast and Slow. Farrar, Strauss and Giroux, S.I. 2011.

    4. Van Regenmortel MHV. Design in biology and rational design in vaccinology: A conceptual analysis. Methods;2021. https://doi.org/10.1016/j.met.2021.07.010

    5. Van Regenmortel MHV. An outdated notion of antibody specificity is one the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from developing an effective HIV-1 vaccine. Front Immunol. 2014;5:593. https://doi.org/103389/fimmu. 2014.00593

    Planned Articles

    1. Dr. Marc H.V. Van Regenmortel: Old and new paradigms in HIV vaccine research

    2. Dr. Vladimir N. Uversky: Intrinsic disorder bottleneck of viral vaccinology

    3. Dr. Kenneth J. Lundström: Therapeutic and prophylactic applications of self-replicating RNA viruses

    4. Dr. Helder Nakaya: Uncovering the role of the transcription factor CREBI in HIV vaccine-induced immunity

    5. Dr. Christine Jacomet: A proposed new paradigm for an AIDS  tolerogenic vaccine

    Keywords: Paradigm, temptation, vaccine

    Call for Papers

    Published Articles

    Open Access
    Filoviridae: insights into immune responses to Ebola virus
    Ebola virus (EBOV) is a zoonotic virus comprising of six known different species, designated within the family Filoviridae and genus Ebolavirus. The first recorded outbreak of an EBOV disease (EVD)  [...] Read more.
    Brent Brown ... Ingo Fricke
    Published: April 25, 2024 Explor Immunol. 2024;4:238–266
    DOI: https://doi.org/10.37349/ei.2024.00139
    Times Cited: 0
    Open Access
    Exploring the possible link between the spike protein immunoglobulin G4 antibodies and cancer progression
    Repeated inoculation with messenger RNA (mRNA) vaccines elicits immunoglobulin G4 (IgG4) antibody production. Such an increase in the concentration of specific and non-specific IgG4 antibodies allow [...] Read more.
    Mikolaj Raszek ... Alberto Rubio-Casillas
    Published: April 25, 2024 Explor Immunol. 2024;4:267–284
    DOI: https://doi.org/10.37349/ei.2024.00140
    Times Cited: 0
    Open Access
    Paradigm of immune dysregulation in coronavirus disease-2019 infection
    The coronavirus disease 2019 (COVID-19) pandemic cost 7–8 million deaths worldwide, creating an unprecedented health and economic crisis. Affecting 700 million people globally, the magnitude of th [...] Read more.
    Om Saswat Sahoo ... Subhradip Karmakar
    Published: January 31, 2024 Explor Immunol. 2024;4:1–33
    DOI: https://doi.org/10.37349/ei.2024.00126
    Times Cited: 0
    Open Access
    Immunopathogenesis of Orthopoxviridae: insights into immunology from smallpox to monkeypox (mpox)
    Since 2019, notable global viral outbreaks have occurred necessitating further research and healthcare system investigations. Following the coronavirus disease 2019 (COVID-19) pandemic, in 2022, whi [...] Read more.
    Brent Brown ... Enrique Chacon-Cruz
    Published: November 21, 2023 Explor Immunol. 2023;3:525–553
    DOI: https://doi.org/10.37349/ei.2023.00119
    Times Cited: 0
    Open Access
    Effect of coronavirus disease 2019 on the vaccine development paradigm
    Vaccines are prophylactic medical products effectively used against infectious diseases. Although a high amount of vaccine studies are conducted at the preclinical stage, the number of approved vacc [...] Read more.
    Sezer Okay
    Published: October 10, 2023 Explor Immunol. 2023;3:433–441
    DOI: https://doi.org/10.37349/ei.2023.00111
    Times Cited: 0
    Open Access
    The emergence of nanovaccines as a new paradigm in virological vaccinology: a review
    Vaccination has made an enormous contribution to global health. Treatment resistance for infectious diseases is growing quickly, and chemotherapeutic toxicity in cancer means that vaccines must be m [...] Read more.
    Chittaranjan Baruah ... Bhabesh Deka
    Published: August 31, 2023 Explor Immunol. 2023;3:361–383
    DOI: https://doi.org/10.37349/ei.2023.00107
    Times Cited: 0
    Open Access
    Fight fire with fire: the need for a vaccine based on intrinsic disorder and structural flexibility
    The absence of advancement in finding efficient vaccines for several human viruses, such as hepatitis C virus (HCV), human immunodeficiency virus type 1 (HIV-1), and herpes simplex viruses (HSVs) de [...] Read more.
    Vladimir N. Uversky
    Published: October 31, 2022 Explor Immunol. 2022;2:731–748
    DOI: https://doi.org/10.37349/ei.2022.00079
    Times Cited: 0
    Open Access
    Therapeutic and prophylactic applications of self-replicating RNA viruses
    Self-replicating RNA viruses have been commonly used for preventive and therapeutic interventions in the fields of infectious diseases and cancers. Both RNA viruses with single-stranded RNA genomes  [...] Read more.
    Kenneth Lundstrom
    Published: May 18, 2022 Explor Immunol. 2022;2:264–292
    DOI: https://doi.org/10.37349/ei.2022.00050
    Open Access
    A proposed new paradigm for an anti-AIDS tolerogenic vaccine
    Until now, despite 30 years of intensive work, the RV144 human immunodeficiency virus (HIV) vaccine trial initiated in 2003 remains so far the most protective vaccine prototype of all those tested ( [...] Read more.
    Christine Jacomet
    Published: April 24, 2022 Explor Immunol. 2022;2:211–219
    DOI: https://doi.org/10.37349/ei.2022.00046
    Times Cited: 0
    Open Access
    Paradigms in HIV vaccine research
    Although a large number of preventative human immunodeficiency virus (HIV) vaccine trials have been carried out during the last 30 years, it is remarkable that an effective HIV vaccine has not yet b [...] Read more.
    Marc H.V. Van Regenmortel
    Published: March 17, 2022 Explor Immunol. 2022;2:180–184
    DOI: https://doi.org/10.37349/ei.2022.00043
    Times Cited: 0